Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib in Severe Autoimmune Encephalitis
DRKS00017497Phase 2Recruiting
- Sponsor
- Friedrich Schiller University Jena
- Start
- Nov 2019
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Autoimmune Encephalitis (AE) comparing Bortezomib + dexamethasone with Placebo + dexamethasone (2 arms). Started Nov 2019; status: recruiting.
02
Drugs
bortezomib
03
Conditions
Autoimmune Encephalitis (AE)
Beyond the preview
Go deeper on DRKS00017497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00017497.